About Glycadia  |  Directors

Arthur Rubenstein, MD, MBBCh

Dr. Rubenstein is Executive Vice President of the University of Pennsylvania Health System and Dean of the University of Pennsylvania School of Medicine. Previously, Dr. Rubenstein served as Dean of the Mount Sinai School of Medicine, where he also was the Gustave L. Levy Distinguished Professor, and as Chairman of the Department of Medicine at the University of Chicago Pritzker School of Medicine, where he also was the Lowell T. Coggeshall Distinguished Service Professor of Medical Sciences. Dr. Rubenstein is internationally recognized for clinical expertise and groundbreaking research in diabetes. His numerous awards and prizes include the Banting Medal from the American Diabetes Association, the David Rumbough Scientific Award from the Juvenile Diabetes Association, the Robert H. Williams Distinguished Chair of Medicine, the highest honor of the Association of Professors of Medicine, and the John Phillips Memorial Award from the American College of Physicians. Author of more than 350 publications, Dr. Rubenstein has held several editorial advisory positions and has served as President of the Association of Professors of Medicine and of the Association of American Physicians, and on study sections of the National Institutes of Diabetes, Digestive and Kidney Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences.

Morton Goldberg, DSc

Dr. Goldberg has been Vice-President of Research, Development and Regulatory Affairs at ICI Pharmaceutical Group, and Vice President, ICI Americas, where he was responsible for scientific and administrative direction of pharmaceutical research and development functions of over 700 scientists in drug discovery, safety evaluation, pharmaceutical development, clinical research, and regulatory affairs. Previously, Dr. Goldberg was Vice-President of Biomedical Research at Stuart Pharmaceuticals, Director of the Department of Pharmacology at the Squibb Institute for Medical Research and Director of the Department of Pharmacodynamics at the Warner Lambert Research Institute. Dr. Goldberg is Clinical Professor of Pharmacology and Experimental Therapeutics at the University of Pennsylvania and serves on several corporate boards in the biotechnology sector.

Joseph Dresner

Mr. Dresner is Chairman of the Highland Companies, a diversified real estate development and management organization. He is a private investor in various entities, is Chairman of the Investment Committee and a member of the Finance Committee of the Board of Directors of Meadowbrook Insurance Group (NYSE: MIG), is Chairman of the Audit Committee of the Board of Directors of New Media Lottery Services PLC (trades on London AIM), and is a member of the Audit and Corporate Governance Committees of Peninsula Bank, a private company in Englewood, Florida. Mr. Dresner is a graduate of the University of Michigan.